Phase 2 Obesity Trial, Recruiting NCT06703788 Sponsor: Chang Gung Memorial Hospital Condition: Obesity
Back to Obesity

Phase 2 Obesity Trial, Recruiting

NCT06703788
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 20 and 75 years old and are covered by health insurance
  • You are a man with a waist circumference of 90 cm (about 35.5 inches) or more, or a woman with a waist circumference of 80 cm (about 31.5 inches) or more
  • Your fasting blood sugar is 100 mg/dL or higher, or you are already taking medication to control your blood sugar
  • Your blood pressure readings are 130/85 mmHg or higher, or you are already taking medication to control your blood pressure
  • Your triglycerides (a type of fat in the blood) are 150 mg/dL or higher, or your "good" cholesterol (HDL) is low (under 40 mg/dL for men or under 50 mg/dL for women), or you are on medication for either of these
  • You have a BMI of 37.5 or higher, or a BMI of 32.5 or higher along with serious related health conditions such as poorly controlled type 2 diabetes, high blood pressure, sleep apnea, or fatty liver

Who may not be able to join:

  • You are currently pregnant or breastfeeding
  • You have an uncontrolled thyroid condition or an adrenal gland disorder
  • You have been diagnosed with a neurological or psychiatric (mental health) condition
  • You have significant liver or kidney problems (confirm with trial site)
  • You have had a serious infection or major surgery within the past month
  • You have a significant problem with your vision or hearing
  • You are currently taking part in another clinical trial involving medication
  • You have received Chinese herbal medicine, acupuncture, or other traditional Chinese medicine treatments for obesity or metabolic conditions within the past month
  • You are a heavy smoker, or have issues with alcohol or substance use
  • You have a serious illness such as cancer or an autoimmune disease

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Registry
ClinicalTrials.gov
Start date
20 November 2024
Est. completion
1 June 2025

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

The composite metabolic endpoint

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov